Sonia Gulati
Chief Executive Officer at Leukovet
Net worth: 185 610 $ as of 31/01/2023
Profile
Sonia Gulati is currently the Chief Executive Officer & Director at Leukovet.
She is also a Director at TigaTx, Inc. and an Investment Review Committee Member at Accelerate Long Island (Venture Capital).
Previously, she was a Director at Actinobac Biomed, Inc., Pinpoint Therapeutics, Inc., and 1200 Pharma LLC.
She was also an Assistant Director at New York Ventures.
Dr. Gulati received her undergraduate degree from Barnard College and her doctorate from Columbia University School of the Arts in 2011.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
HOMESFY REALTY LTD.
1.16% | 02/01/2023 | 35,511 ( 1.16% ) | 185 610 $ | 31/01/2023 |
Sonia Gulati active positions
Companies | Position | Start |
---|---|---|
Leukovet
Leukovet Pharmaceuticals: MajorHealth Technology Leukovet develops peptide-based cancer therapeutics for the treatment of canine lymphoma, leukemia, and other immunological diseases. The company is based in New York, NY. The company was founded in 2019. The CEO is Sonia Gulati. | Chief Executive Officer | - |
Accelerate Long Island (Venture Capital)
Accelerate Long Island (Venture Capital) Investment ManagersFinance Accelerate Long Island/venture capital/ (Accelerate Long Island (Venture Capital)) is a venture capital firm, a subsidiary of Accelerate Long Island, Inc founded in 2016. The firm is headquartered in Melville, New York. | Private Equity Investor | - |
TigaTx, Inc.
TigaTx, Inc. BiotechnologyHealth Technology TigaTx, Inc. is a biotechnology company that focuses on developing first-in-class, engineered IGA as neutrophil engagers to fight cancer. The company is based in Boston, MA. TigaTx is backed by excellent investors and has an accomplished scientific advisory board. It was founded by Jeanette Leusen and the CEO is Anne Altmeyer. | Director/Board Member | 01/09/2009 |
Former positions of Sonia Gulati
Companies | Position | End |
---|---|---|
Actinobac Biomed, Inc.
Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Actinobac Biomed, Inc. operates as a biopharmaceutical company developing therapeutics. It offers therapeutics for indications, including blood cancers, autoimmune, inflammatory diseases and HIV. The company was founded by Scott C. Kachlany in 2009 and is headquartered in Kendall Park, NJ. | Director/Board Member | 30/09/2021 |
1200 Pharma LLC
1200 Pharma LLC Pharmaceuticals: MajorHealth Technology 1200 Pharma LLC engages in the provision of pre-clinical drug discovery and clinical approval timelines. The company is headquartered in Pasadena, CA. | Director/Board Member | 31/08/2021 |
Pinpoint Therapeutics, Inc.
Pinpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pinpoint Therapeutics, Inc. provides cancer treatment. The firm specializes in developing novel treatments for cancer. The company was founded by Jeffrey Winkler and Ravi Amaravadi in 2018 and is headquartered in Philadelphia, PA. | Director/Board Member | 31/08/2021 |
New York Ventures
New York Ventures Investment ManagersFinance New York Ventures (New York State Innovation) is a venture capital subsidiary of Empire State Development Corp. The firm is headquartered in New York. | Private Equity Investor | 31/12/2018 |
Training of Sonia Gulati
Barnard College | Undergraduate Degree |
Columbia University School of the Arts | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 7 |
---|---|
Actinobac Biomed, Inc.
Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Actinobac Biomed, Inc. operates as a biopharmaceutical company developing therapeutics. It offers therapeutics for indications, including blood cancers, autoimmune, inflammatory diseases and HIV. The company was founded by Scott C. Kachlany in 2009 and is headquartered in Kendall Park, NJ. | Health Technology |
New York Ventures
New York Ventures Investment ManagersFinance New York Ventures (New York State Innovation) is a venture capital subsidiary of Empire State Development Corp. The firm is headquartered in New York. | Finance |
1200 Pharma LLC
1200 Pharma LLC Pharmaceuticals: MajorHealth Technology 1200 Pharma LLC engages in the provision of pre-clinical drug discovery and clinical approval timelines. The company is headquartered in Pasadena, CA. | Health Technology |
Accelerate Long Island (Venture Capital)
Accelerate Long Island (Venture Capital) Investment ManagersFinance Accelerate Long Island/venture capital/ (Accelerate Long Island (Venture Capital)) is a venture capital firm, a subsidiary of Accelerate Long Island, Inc founded in 2016. The firm is headquartered in Melville, New York. | Finance |
Pinpoint Therapeutics, Inc.
Pinpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pinpoint Therapeutics, Inc. provides cancer treatment. The firm specializes in developing novel treatments for cancer. The company was founded by Jeffrey Winkler and Ravi Amaravadi in 2018 and is headquartered in Philadelphia, PA. | Health Technology |
Leukovet
Leukovet Pharmaceuticals: MajorHealth Technology Leukovet develops peptide-based cancer therapeutics for the treatment of canine lymphoma, leukemia, and other immunological diseases. The company is based in New York, NY. The company was founded in 2019. The CEO is Sonia Gulati. | Health Technology |
TigaTx, Inc.
TigaTx, Inc. BiotechnologyHealth Technology TigaTx, Inc. is a biotechnology company that focuses on developing first-in-class, engineered IGA as neutrophil engagers to fight cancer. The company is based in Boston, MA. TigaTx is backed by excellent investors and has an accomplished scientific advisory board. It was founded by Jeanette Leusen and the CEO is Anne Altmeyer. | Health Technology |
- Stock Market
- Insiders
- Sonia Gulati